Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

22.02

-2.00 (-8.33%)

At close: Apr 1, 2025, 4:00 PM

22.50

+0.48 (2.18%)

After-hours: Apr 1, 2025, 6:52 PM EDT

Vera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	1,404	2,678	683	535	569	-	Upgrade
Market Cap Growth	291.87%	291.87%	27.69%	-5.87%	-	-	Upgrade
Enterprise Value	818	2,380	553	433	482	-	Upgrade
Last Close Price	22.02	42.29	15.38	19.35	26.72	-	Upgrade
PB Ratio	2.42	4.64	6.72	6.96	8.17	-	Upgrade
P/TBV Ratio	4.64	4.64	6.72	6.96	8.17	-	Upgrade
Debt / Equity Ratio	0.10	0.10	0.53	0.41	0.07	-	Upgrade
Quick Ratio	25.41	25.41	7.23	4.48	10.36	22.36	Upgrade
Current Ratio	25.67	25.67	7.71	4.91	10.73	22.55	Upgrade
Return on Equity (ROE)	-44.83%	-44.83%	-107.50%	-121.58%	-54.43%	-198.65%	Upgrade
Return on Assets (ROA)	-25.14%	-25.14%	-41.54%	-52.81%	-31.09%	-102.70%	Upgrade
Return on Capital (ROIC)	-26.55%	-26.55%	-48.38%	-62.19%	-34.47%	-114.19%	Upgrade
Earnings Yield	-10.84%	-5.68%	-14.05%	-16.64%	-5.74%	-	Upgrade
FCF Yield	-9.66%	-5.07%	-13.50%	-12.64%	-4.17%	-	Upgrade
Buyback Yield / Dilution	-29.55%	-29.55%	-60.73%	-97.76%	-4099.14%	-8.34%	Upgrade

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q